Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 7.36 0.35 (4.99%) Market Cap: 977.63 Mil Enterprise Value: 940.11 Mil PE Ratio: 0 PB Ratio: 2.37 GF Score: 82/100

Q1 2023 Maravai LifeSciences Holdings Inc Earnings Call Transcript

May 08, 2023 / 09:00PM GMT
Release Date Price: $13.9 (-3.94%)
Operator

Good afternoon. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to the Maravai Life Sciences First Quarter 2023 Earnings Conference Call. (Operator Instructions) Deb Hart, Head of Investor Relations, you may begin your conference.

Debra Hart
Maravai LifeSciences Holdings, Inc. - Senior Director of IR

Thank you, Rob, and good afternoon, everyone. Thanks for joining us on our first quarter 2023 earnings call. Our press release and the slides that accompany today's call are posted on our website and are available at investors.maravai.com.

As you can see on our agenda for today on Slide 2, Carl will first provide you with a business update, then Kevin will review our financial results and guidance. Trey Martin, President of our Biologics Safety Testing; Drew Burch, Executive Vice President, Nucleic Acid Products; and Becky Buzzeo, our Chief Commercial Officer, will join the call for the question-and-answer session following the prepared remarks.

We remind you, management will make

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot